Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.850
+0.050 (2.78%)
At close: Dec 20, 2024, 4:00 PM
1.890
+0.040 (2.16%)
After-hours: Dec 20, 2024, 4:27 PM EST
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $111.15 million as of December 20, 2024. Its market cap has decreased by -31.70% in one year.
Market Cap
111.15M
Enterprise Value
-117.76M
1-Year Change
-31.70%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $111.15M, a decrease of -82.03%. That is a compound annual growth rate of -38.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 111.15M | -50.02% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardiol Therapeutics | 111.66M |
| MultiPlan | 110.77M |
| Cassava Sciences | 110.65M |
| Editas Medicine | 110.61M |
| MediciNova | 108.57M |
| Tenaya Therapeutics | 108.14M |
| Leap Therapeutics | 106.91M |
| Protara Therapeutics | 106.76M |